Educational Information Only
The following is a summary of published preclinical research and is provided for informational and educational purposes only. No information in this article constitutes a claim that any product sold by Ovrform treats, cures, prevents, or mitigates any disease or medical condition. All referenced studies were conducted in non-human models unless otherwise specified. This content does not constitute medical advice and should not be relied upon as a substitute for consultation with a qualified healthcare professional. Ovrform does not endorse or recommend the use of any product for human or veterinary purposes.
This article is published for educational and informational purposes only. It is not medical advice, not a diagnosis or treatment recommendation, and not guidance for use of any kind. Independent third-party research described here does not represent claims about Ovrform products, and no outcome, benefit, or effect should be inferred for any Ovrform product. Where published study methods are reported, amounts, routes, and schedules are described only to characterize that research accurately — they are not instructions, protocols, or recommendations, and Ovrform does not provide dosing or administration guidance. All Ovrform products are supplied for laboratory research use only and are not for human or animal consumption or use.
Structural Reference · Regulatory Heptapeptides
Semax vs Selank
A structural and chemical comparison across peptide origin, amino acid sequence, charge and polarity, molecular complexity, analytical profile, and laboratory format. Limited to characterization only, with no physiological, administration, or clinical content.
ACTH(4-10) analog
Semax
7 RESIDUES
Synthetic linear heptapeptide modeled on an ACTH fragment, extended with a Pro-Gly-Pro terminal motif.
Tuftsin analog
Selank
7 RESIDUES
Synthetic linear heptapeptide modeled on tuftsin, extended with the same Pro-Gly-Pro terminal motif.
Neutral, research-use-only reference articles on peptide classification, structure, and analytical documentation. These articles summarize independently published third-party literature. The studies and their authors are not affiliated with, sponsored by, or endorsed by Ovrform, and nothing here describes or implies any use of Ovrform products.
Key Takeaways
Two stabilized heptapeptides from two different parent molecules
Semax and Selank are short synthetic peptides commonly compared in neuropeptide research. Both are stabilized heptapeptide analogs derived from endogenous regulatory peptides, but they originate from different parent molecules and have distinct amino acid sequences, charge profiles, and chemical characteristics.
- Semax is based on the ACTH(4-10) fragment of adrenocorticotropic hormone.
- Selank is based on tuftsin, an endogenous tetrapeptide.
- Both compounds include a C-terminal Pro-Gly-Pro sequence intended to improve resistance to enzymatic degradation.
This comparison focuses exclusively on classification, peptide sequences, molecular properties, analytical characteristics, and physical laboratory format. It does not address physiological effects, research outcomes, administration, or clinical use. All information is provided for research-use-only characterization.
01 · Primary Distinction
What is the main difference between Semax and Selank?
The primary difference is the regulatory peptide from which each compound was derived. Semax is an analog of the ACTH(4-10) peptide fragment. Selank is an analog of the immunomodulatory peptide tuftsin.
Reported sequence
Semax
Met-Glu-His-Phe-Pro-Gly-Pro
Analog of the ACTH(4-10) peptide fragment of adrenocorticotropic hormone.
Reported sequence
Selank
Thr-Lys-Pro-Arg-Pro-Gly-Pro
Analog of tuftsin, an endogenous immunomodulatory tetrapeptide.
Although both compounds contain seven amino acids and share the terminal Pro-Gly-Pro motif, their first four residues are different. This difference gives each peptide a distinct chemical identity, charge distribution, polarity, and analytical behavior.
02 · At a Glance
Comparison table
| Property | Semax | Selank |
|---|---|---|
| Peptide type | Synthetic linear heptapeptide | Synthetic linear heptapeptide |
| Parent peptide | ACTH(4-10) fragment | Tuftsin |
| Reported sequence | Met-Glu-His-Phe-Pro-Gly-Pro | Thr-Lys-Pro-Arg-Pro-Gly-Pro |
| Amino acid length | 7 residues | 7 residues |
| Shared terminal motif | Pro-Gly-Pro | Pro-Gly-Pro |
| General charge profile | Mixed ionization profile | Comparatively basic |
| Basic residues | Histidine | Lysine and arginine |
| Acidic residues | Glutamate | None in the reported sequence |
| Disulfide bridges | None | None |
| Cyclization | None | None |
| Glycosylation | None | None |
| Common laboratory format | Lyophilized powder | Lyophilized powder |
| Common identity testing | HPLC and mass spectrometry | HPLC and mass spectrometry |
03 · Classification
Classification and peptide origin
Semax
Semax is a synthetic heptapeptide modeled on the ACTH(4-10) fragment of adrenocorticotropic hormone. The ACTH-derived core is extended with a Pro-Gly-Pro tripeptide at the C-terminus. This terminal sequence is incorporated as a stabilizing structural feature intended to reduce the rate of proteolytic degradation compared with the unmodified parent fragment. It is not a full-length hormone or a complex protein biologic.
Selank
Selank is a synthetic heptapeptide modeled on tuftsin, an endogenous tetrapeptide with the sequence Thr-Lys-Pro-Arg. Like Semax, Selank includes a Pro-Gly-Pro extension at its C-terminus, producing the complete reported sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. Although Semax and Selank share a similar design strategy, Selank does not originate from ACTH or the melanocortin peptide family.
Semax is generally classified as
- A synthetic oligopeptide
- A linear heptapeptide
- A non-glycosylated peptide
- An ACTH-fragment analog
- A regulatory-peptide research material
Selank is generally classified as
- A synthetic oligopeptide
- A linear heptapeptide
- A non-glycosylated peptide
- A tuftsin analog
- A regulatory-peptide research material
04 · Sequences
Amino acid sequences
The amino acid sequence is one of the clearest distinctions between the two peptides. The first four residues reflect each compound’s lineage — ACTH fragment for Semax, tuftsin for Selank.
Semax
Met-Glu-His-Phe-Pro-Gly-Pro
First four residues:
- Methionine
- Glutamate
- Histidine
- Phenylalanine
Selank
Thr-Lys-Pro-Arg-Pro-Gly-Pro
First four residues:
- Threonine
- Lysine
- Proline
- Arginine
Shared structural motif
Pro-Gly-Pro
This proline-rich terminal segment is the main architectural feature shared by the two compounds. It also distinguishes each synthetic analog from its unmodified endogenous template.
05 · Shared vs Distinct
Structural similarities and differences
Their common design can be described as a short regulatory-peptide sequence connected to a proline-rich stabilizing segment. Neither compound requires the complex folding, disulfide bonding, or higher-order structure associated with larger protein molecules. The most significant difference is found in the first four amino acids: Semax contains glutamate, histidine, phenylalanine, and methionine, while Selank contains threonine, lysine, proline, and arginine.
Shared structural features
- Composed of seven amino acid residues
- Linear rather than cyclic
- Non-glycosylated
- Free of disulfide bridges
- Small relative to protein biologics
- Built from an endogenous peptide-derived core
- Extended with a Pro-Gly-Pro terminal motif
Properties affected by sequence differences
- Net charge
- Side-chain polarity
- Hydrophobicity
- Ionization across different pH conditions
- Chromatographic retention
- Solvent and buffer compatibility
- Oxidative sensitivity
The shared Pro-Gly-Pro sequence does not make the two peptides chemically interchangeable. Each has a distinct molecular identity and should be evaluated using compound-specific analytical methods.
06 · Charge & Polarity
Charge and polarity comparison
Selank generally has a more basic character because its sequence contains both lysine and arginine. These amino acids possess side chains that are positively charged under many common laboratory conditions.
Semax has a more mixed ionization profile. It contains glutamate, which has an acidic side chain, and histidine, whose charge state can change within biologically and analytically relevant pH ranges.
This difference may influence
- Solubility under specific buffer conditions
- Ion-exchange chromatography
- Electrophoretic migration
- Reversed-phase HPLC retention
- Method development for purity testing
- Reconstitution and stability studies
Exact behavior depends on factors such as pH, ionic strength, counterion form, concentration, solvent composition, and peptide purity.
07 · Size & Complexity
Molecular size and chemical complexity
Semax and Selank both belong to the heptapeptide size class. They are substantially smaller and structurally simpler than protein biologics. Neither peptide contains:
- Disulfide-linked cysteine residues
- Carbohydrate groups
- Multiple folded protein domains
- A cyclic backbone
- Complex post-translational modifications
08 · Analytical Testing
Analytical testing of Semax and Selank
High-performance liquid chromatography and mass spectrometry are commonly used to evaluate synthetic peptides in this category.
High-performance liquid chromatography
HPLC may be used to assess peptide purity, retention time, related impurities, degradation products, and batch consistency. Differences in polarity and side-chain composition mean that Semax and Selank may display different retention behavior under the same chromatographic conditions.
Mass spectrometry
Mass spectrometry may be used to confirm molecular mass, peptide identity, expected ion patterns, potential degradation products, and oxidation or other chemical changes. Analytical results should be interpreted alongside the peptide sequence, counterion form, water content, and stated material specifications.
Peptide purity
Retention time
Related impurities
Degradation products
Batch consistency
Molecular mass
Expected ion patterns
Oxidation screening
09 · Laboratory Format
Physical format and presentation
Semax and Selank research materials are commonly supplied as lyophilized powders in sealed laboratory vials. Lyophilization removes water under controlled low-temperature and reduced-pressure conditions. This format is frequently selected to improve solid-state stability before laboratory reconstitution.
The appearance of a lyophilized peptide may vary according to peptide quantity, excipients, residual moisture, lyophilization conditions, vial dimensions, and manufacturing process. Visual appearance alone cannot confirm identity, purity, concentration, or integrity.
10 · Reconstitution & Stability
Reconstitution and stability considerations
For laboratory analysis, lyophilized peptides are generally dissolved in an aqueous or buffered solvent selected for the specific experimental method. Relevant variables may include:
- Target concentration
- Ionic strength
- Solvent compatibility
- Freeze-thaw exposure
- Storage duration
- Required pH
- Buffer composition
- Adsorption to laboratory surfaces
- Light exposure
Reconstituted peptide solutions are generally more vulnerable to degradation than dry lyophilized material. Semax contains a methionine residue, which may be susceptible to oxidation under certain storage or handling conditions. This potential sensitivity may be relevant when designing stability studies or interpreting mass-spectrometry results.
Actual storage and reconstitution requirements should be based on the supplier’s validated documentation and the requirements of the analytical protocol.
No administration supplies
Ovrform does not sell bacteriostatic water, sterile water for injection, syringes, needles, alcohol pads, or reconstitution kits, and does not bundle any product with such items. We do not provide reconstitution, dilution, dosing, or administration instructions, and we do not refer customers to any source for these items.
10 · FAQ
Frequently asked questions
Are Semax and Selank the same type of peptide?
They belong to the same broad structural category because both are synthetic, linear heptapeptide analogs with a Pro-Gly-Pro terminal motif. They are not the same compound. Semax is derived from an ACTH fragment, while Selank is derived from tuftsin, and their different sequences produce distinct chemical, ionic, and analytical profiles.
Do Semax and Selank have the same sequence?
No. They share only the terminal Pro-Gly-Pro sequence. Semax is reported as Met-Glu-His-Phe-Pro-Gly-Pro and Selank as Thr-Lys-Pro-Arg-Pro-Gly-Pro. The first four amino acids are different, which gives each peptide its own molecular identity.
Why do both peptides contain Pro-Gly-Pro?
The Pro-Gly-Pro motif is used as a stabilizing terminal sequence in both compounds. Its inclusion is intended to improve resistance to enzymatic degradation relative to the original endogenous peptide fragments, and it contributes to the proline-rich structural character shared by the two.
Is Selank more basic than Semax?
Selank generally has a more basic sequence because it contains lysine and arginine. Semax contains glutamate and histidine, giving it a more mixed and pH-dependent ionization profile. The precise net charge of either peptide depends on pH, terminal groups, counterions, and other formulation variables.
Can the same analytical method be used for both peptides?
A general analytical platform may be used for both compounds, but the method conditions may need to be adjusted. Because they differ in charge, polarity, and side-chain composition, they may behave differently during reversed-phase HPLC, ion-exchange chromatography, electrophoresis, and mass-spectrometry analysis. Compound-specific method validation is therefore important.
Can appearance confirm peptide identity?
No. Visual appearance of a lyophilized powder cannot confirm identity, purity, concentration, or integrity. Identity must be supported by analytical testing and lot-specific documentation.
Conclusion
One design strategy, two molecular identities
Semax and Selank are synthetic linear heptapeptides that share a common Pro-Gly-Pro terminal motif but originate from different endogenous peptide templates. Semax is derived from the ACTH(4-10) fragment and has the reported sequence Met-Glu-His-Phe-Pro-Gly-Pro. Selank is derived from tuftsin and has the reported sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro.
Their primary chemical differences involve amino acid composition, charge, polarity, ionization behavior, and potential analytical retention characteristics. Both are commonly supplied as lyophilized research materials and may be characterized through methods such as HPLC and mass spectrometry. This comparison is limited to chemical and research-material characterization; it does not describe physiological effects, clinical outcomes, administration, or human use.